Schizophrenia News

Cat ownership in pregnancy or early childhood was not associated with increased risk for psychotic experiences, according to recent findings.

Aequus recently announced completion of dosing in its second proof-of-concept clinical trial for AQS1301, a once-weekly transdermal patch for aripiprazole.

Preliminary findings indicated vitamin B supplementation improved psychiatric symptoms among individuals with schizophrenia.

Inadequate maternal weight gain during pregnancy was associated with increased risk for psychoses in offspring, according to recent findings.

Researchers from the University of Maryland recently published findings on a blood test they developed that may improve diagnosis of schizophrenia and other disorders.

Infections were associated with increased risk for schizophrenia and affective disorders, particularly those treated with antibiotics and requiring hospitalization, according to recent findings.

Schizophrenia was associated with a significantly increased risk for diabetes, which further increased with use of first- and second-generation antipsychotics.

Sunovion recently announced that the FDA approved a supplemental New Drug Application for Latuda for the treatment of schizophrenia in adolescents aged 13 to 17 years.

Individuals with 22q11.2 deletion or duplication were significantly more likely to develop a psychiatric disorder, according to recent findings.

Recent findings indicated glucose homeostasis differed among individuals with first-episode schizophrenia who had never taken antipsychotics, compared with healthy controls.